Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Murray

Showing results (1201-1210 of 1,213) with videos related to

Pageof 122
Sort By:
Plos Medicine|September 12, 2019
Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysisOmowunmi Aibana, Chuan-Chin Huang, Said Aboud, et al.
Journal of Asthma and Allergy|January 20, 2022
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE StudyAndrew N Menzies-Gow, Claire McBrien, Bindhu Unni, et al.
Science (New York, N.Y.)|January 26, 2013
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMOVictoria E Clark, E Zeynep Erson-Omay, Akdes Serin, et al.
Chest|April 22, 2021
Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma CohortLiam G Heaney, Luis Perez de Llano, Mona Al-Ahmad, et al.
BMC Medical Research Methodology|August 22, 2020
International severe asthma registry (ISAR): protocol for a global registryJ Mark FitzGerald, Trung N Tran, Marianna Alacqua, et al.
Journal of Asthma and Allergy|October 28, 2022
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic TherapyWenjia Chen, Mohsen Sadatsafavi, Trung N Tran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 6, 2022
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe AsthmaCeleste M Porsbjerg, Andrew N Menzies-Gow, Trung N Tran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2025
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Trung N Tran, Ghislaine Scelo, et al.
American Journal of Respiratory and Critical Care Medicine|November 28, 2023
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe AsthmaMichael E Wechsler, Ghislaine Scelo, Désirée E S Larenas-Linnemann, et al.
Pageof 122

Showing results (1201-1210 of 1,213) with videos related to

Sort By:
Pageof 122
Plos Medicine|September 12, 2019
Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysisOmowunmi Aibana, Chuan-Chin Huang, Said Aboud, et al.
Journal of Asthma and Allergy|January 20, 2022
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE StudyAndrew N Menzies-Gow, Claire McBrien, Bindhu Unni, et al.
Science (New York, N.Y.)|January 26, 2013
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMOVictoria E Clark, E Zeynep Erson-Omay, Akdes Serin, et al.
Chest|April 22, 2021
Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma CohortLiam G Heaney, Luis Perez de Llano, Mona Al-Ahmad, et al.
BMC Medical Research Methodology|August 22, 2020
International severe asthma registry (ISAR): protocol for a global registryJ Mark FitzGerald, Trung N Tran, Marianna Alacqua, et al.
Journal of Asthma and Allergy|October 28, 2022
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic TherapyWenjia Chen, Mohsen Sadatsafavi, Trung N Tran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 6, 2022
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe AsthmaCeleste M Porsbjerg, Andrew N Menzies-Gow, Trung N Tran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2025
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Trung N Tran, Ghislaine Scelo, et al.
American Journal of Respiratory and Critical Care Medicine|November 28, 2023
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe AsthmaMichael E Wechsler, Ghislaine Scelo, Désirée E S Larenas-Linnemann, et al.
Pageof 122